The loss of coverage for thousands of Arizonans reliant on the Flovent inhaler was not the result of GlaxoSmithKline ...
A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
Maggie Hassan. The setup forced many users to pay higher prices and allowed the British drugmaker to avoid paying Medicaid ...
WASHINGTON, June 27 (Reuters) - U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's (GSK.L), opens new tab decision to ...
It’s been a turbulent few days for GSK’s respiratory business: On Tuesday, the U.S. Federal Trade Commission (FTC) further cracked down on “junk patent listings,” including those related to a quartet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results